In situations where you may possibly involve entry to a medically-needed drug for a significant or everyday living-threatening condition exactly where there is absolutely no sector approved drug readily available in copyright and for which alternate common therapies have unsuccessful or are unsuitable, Health copyright's Special Access Programme (S